indazoles has been researched along with Desmoid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ito, K; Koike, H; Nishida, Y; Sakai, T | 1 |
| Italiano, A | 1 |
| Orbach, D; Penel, N; Ryckewaert, T | 1 |
| Bishop, AJ; Ratan, R; Roland, CL | 1 |
| Agresta, L; Dasgupta, R; Kim, H; Nagarajan, R; Plemmons, A; Pressey, JG; Sorger, JI; Szabo, S; Turpin, BK | 1 |
| Baker, LH | 1 |
| Benson, C; Hatcher, H; Jones, RL; Judson, I; Messiou, C; Miah, A; Szucs, Z; van der Graaf, WT; Wong, HH; Zaidi, S | 1 |
1 review(s) available for indazoles and Desmoid
| Article | Year |
|---|---|
Desmoid Fibromatosis: Management in an Era of Increasing Options.
Topics: Antineoplastic Agents; Fibromatosis, Aggressive; Humans; Indazoles; Protein Kinase Inhibitors; Pyrimidines; Sorafenib; Sulfonamides; Watchful Waiting | 2021 |
1 trial(s) available for indazoles and Desmoid
| Article | Year |
|---|---|
Pazopanib therapy for desmoid tumors in adolescent and young adult patients.
Topics: Adolescent; Adult; Angiogenesis Inhibitors; Child; Child, Preschool; Female; Fibromatosis, Aggressive; Follow-Up Studies; Humans; Indazoles; Male; Neoplasm Recurrence, Local; Prognosis; Pyrimidines; Retrospective Studies; Sulfonamides; Young Adult | 2018 |
5 other study(ies) available for indazoles and Desmoid
| Article | Year |
|---|---|
Pazopanib for progressive desmoid tumours: children, persistant effects, and cost.
Topics: Adult; Child; Drug Therapy, Combination; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Pyrimidines; Sulfonamides; Vinblastine | 2019 |
Pazopanib for progressive desmoid tumours: children, persistant effects, and cost - Author's reply.
Topics: Adult; Child; Drug Therapy, Combination; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Pyrimidines; Sulfonamides; Vinblastine | 2019 |
[Systemic treatment for management of aggressive fibromatosis in both adult and children: Level of evidence and unsolved questions].
Topics: Adult; Age Factors; Antineoplastic Agents; Child; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cross-Over Studies; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Proof of Concept Study; Protein Kinase Inhibitors; Pyrimidines; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Sorafenib; Sulfonamides; Vinblastine | 2020 |
The necessity for rigour in rare disease study design.
Topics: Drug Therapy, Combination; Fibromatosis, Aggressive; Humans; Indazoles; Methotrexate; Pyrimidines; Rare Diseases; Research Design; Sulfonamides; Vinblastine | 2019 |
Pazopanib, a promising option for the treatment of aggressive fibromatosis.
Topics: Adult; Female; Fibromatosis, Aggressive; Humans; Indazoles; Male; Middle Aged; Protein Kinase Inhibitors; Pyrimidines; Retrospective Studies; Sulfonamides | 2017 |